Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

10.1245/s10434-007-9494-5
Annals of Surgical Oncology 14:3102-3110 (2007)
© 2007 Society of Surgical Oncology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nathanson, S. D.
Right arrow Articles by Kapke, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Nathanson, S. D.
Right arrow Articles by Kapke, A.

Original Article

Preoperative Identification of the Sentinel Lymph Node in Breast Cancer

S. David Nathanson, MD1, Matthew Burke, MD2, Robert Slater, MD1 and Alissa Kapke, MS3

1 Department of Surgery, Henry Ford Health System, 2799 West Grand Boulevard, Detroit, Michigan 48202, USA
2 Department of Radiology, Henry Ford Health System, 2799 West Grand Boulevard, Detroit, Michigan 48202, USA
3 Department of Biostatistics, Henry Ford Health System, 2799 West Grand Boulevard, Detroit, Michigan 48202, USA

Correspondence: Address correspondence and reprint requests to: S. David Nathanson, MD; E-mail: dnathan1{at}hfhs.org

Background: Preoperative diagnosis of sentinel lymph node (SLN) metastasis would justify a single axillary operation. We hypothesized that ultrasound-guided core needle biopsy (USGCNB) of a morphologically normal or abnormal lymph node in the anatomic position of the SLN would accomplish this goal.

Methods: A total of 179 clinically N0 breast cancer patients underwent high-resolution lower axillary ultrasound (US) evaluation with core needle biopsy and microclip placement of a node when feasible. SLN biopsy was performed in 131 patients and the node X-rayed when appropriate. The node was removed surgically, and the one identified and analyzed preoperatively was compared with it clinically, radiologically and/or pathologically.

Results: A node was seen on US in 145 (81%) of 179 patients, and a core needle biopsy was performed in 121 patients. A total of 3.5 ± 1.38 (mean ± SD) core samples were obtained per node. Of those node biopsy samples, 55 (45.5%) had metastases. Metastasis size was 14.9 ± 10.1 mm. Metastases were found in 9 (13.6%) of 66 patients in whom the needle core was negative; in these falsely negative biopsy samples, the node metastases were 8.73 ± 6.24 mm (P = .120). Eight (33.3%) of 24 nodes that did not undergo biopsy had metastases. Seven (20.6%) of 34 of those not seen on US had SLN metastases. In 47 (78.3%) of 60 patients, the node that underwent core needle biopsy was the SLN found by the surgeon during surgery (P < .001).

Conclusions: Preoperative identification, core needle biopsy, and documentation of metastasis in the first SLN in breast cancer was achieved by focused lower ipsilateral axillary US. Knowledge of the lymph node status might change the patient’s planned surgery.

Key Words: Preoperative • Biopsy • Sentinel lymph node







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Society of Surgical Oncology.